EC ever use among women of reproductive age: 0.3% (Georgia Reproductive Health Survey 2010)
EC knowledge among women of reproductive age: 5.2% (Georgia Reproductive Health Survey 2010)
Contraceptive Use: 21% (Georgia Reproductive Health Survey 2010)
Registered LNG-EC products:
- Escapelle* - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor* - Available directly from pharmacist without prescription (i.e. BTC)
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: Essential Medicines List
Other relevant information: A product containing ulipristal acetate has been registered but is not yet on the market.
In Georgia, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is pharmacists, after a doctor has prescribed the drug, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
According to the 2010 Georgia Reproductive Health Survey, lack of knowledge of and awareness about this contraceptive method, especially among adolescents, those with less education, and those living in rural areas are significant barriers to use. Only 5% of Georgian women aged 15-44 have an awareness of EC, and only 4% know how EC should be used. Only 4.1% of women aged 15-44 years have knowledge about where to obtain EC. The most important source of information about EC among women aged 15-44 is friends and boyfriends, followed by doctors. (Georgia Reproductive Health Survey 2010, available at http://www.ncdc.ge/uploads/publications/angarishebi/GERHS_2010_%20Final%20Report%20%20ENGL.pdf)